drugset / Trial / NCT00753623
Clinical Management of Neuropathic Pain With Ramelteon
Terminated
23 enrolled
Massachusetts General Hospital
Takeda Pharmaceuticals North America, Inc. · collab
RandomizedCrossoverTriple-blindTreatment
Summary
This proposal is to conduct a double-blinded, randomized, placebo-controlled, crossover clinical study to examine the hypothesis that ramelteon would reduce pain score and improve functional status in subjects with neuropathic pain.
Timeline
- Start
- 2008-09
- Primary completion
- 2010-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ramelteon | Unknown | 8 mg | — |